By Fineline Cube China-based Hotgen Biotech Co., Ltd (SHA: 688068) announced receiving market approval in Russia for its Hotgen COVID-19 antigen home test. The product, used for household testing of novel Coronavirus (2019-nCoV), previously received approvals in the US, the European Union, and the UK.
Global Approvals and Market Expansion
Hotgen Biotech’s COVID-19 antigen home test has now secured approval in Russia, expanding its market reach globally. This approval follows previous clearances in major markets such as the US, the European Union, and the UK, highlighting the product’s reliability and effectiveness in detecting the novel Coronavirus.-Fineline Info & Tech